Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Sees Significant Decline in Short Interest

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) saw a significant drop in short interest in December. As of December 31st, there was short interest totaling 8,463 shares, a drop of 22.9% from the December 15th total of 10,980 shares. Based on an average daily trading volume, of 7,174 shares, the days-to-cover ratio is currently 1.2 days. Based on an average daily trading volume, of 7,174 shares, the days-to-cover ratio is currently 1.2 days.

Alpha Tau Medical Trading Down 12.8%

Shares of Alpha Tau Medical stock traded down $0.14 during trading on Monday, reaching $0.95. The company’s stock had a trading volume of 25,315 shares, compared to its average volume of 113,292. Alpha Tau Medical has a 52 week low of $0.13 and a 52 week high of $1.18. The business’s 50-day moving average price is $0.40 and its 200-day moving average price is $0.33.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.